Clinical Trial Update: M-2018-334 in Hematological Malignancies [NA]

View source ↗

Summary

A Miltenyi Biomedicine-sponsored clinical trial (NCT06225050) evaluating an investigational product for hematologic malignancies is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Miltenyi Biomedicine investigational product

Snippet

Sponsor: Miltenyi Biomedicine GmbH | Conditions: Hematological Malignancies | NA | Status: NOT_YET_RECRUITING